Wholesale of pharmaceutical and medical goods
NORSK LABEX AS
Revenue 2025
NOK 43.1m
Operating profit
NOK −12,000
Equity
NOK 5.4m
Incorporated
1990
Employees
6
Share capital
NOK 400,000
Key figures · 2025
Current ratio
1.53
Equity ratio
35.1%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -0.0% | |
| Net margin (%%) | 0.1% | |
| Return on assets (%%) | -0.1% | |
| Likviditet | ||
| Current ratio | 1.53 | |
| Working capital | 5.3m | |
| Soliditet | ||
| Equity ratio (%%) | 35.1% | |
| Debt-to-equity ratio | 1.85 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.